Lv41
590 积分 2021-08-25 加入
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics
10天前
已完结
Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases
10天前
已完结
Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis
13天前
已完结
Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review
20天前
已完结
Targeting CDK2 to combat drug resistance in cancer therapy
21天前
已完结
High-Grade B-cell Lymphomas: Double Hit and Non-Double Hit
26天前
已完结
Innovative Glucagon-based Therapies for Obesity
1个月前
已关闭
The expanding incretin universe: from basic biology to clinical translation
1个月前
已完结
Molecular Pathology and Therapeutic Strategies of Type 2 Diabetes
1个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of HRS ‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
1个月前
已完结
皖公网安备34019202002308
